The global cholestatic pruritus therapeutics market is experiencing robust growth, driven by increasing prevalence of liver diseases. A significant rise in the number of patients suffering cholestatic pruritus is fueling demand for effective treatment options. The market is characterized by a wide range of therapeutic approaches, including drug-bas